'Anderson cancer center' presentation slideshows

Ovarian Cancer: Standards of Care and New Opportunities

Ovarian Cancer: Standards of Care and New Opportunities. Robert L. Coleman, M.D. Professor & Vice Chair, Clinical Research Department of Gynecologic Oncology M.D. Anderson Cancer Center. Ovarian Cancer: Liner Notes. Globally 7 th most incident and lethal cancer

1.93k views • 62 slides

Reporting on Scientific Journal Articles

Reporting on Scientific Journal Articles. Jeremy Moore, M.A. Senior Manager, Science Communications American Association for Cancer Research jeremy.moore@aacr.org. Why is Cancer Newsworthy?. Why is Cancer Newsworthy?. Number 1 cause of death, surpassing heart disease in 2010.

684 views • 58 slides

Phase II Selection Design with Adaptive Randomization in a Limited-Resource Environment

Phase II Selection Design with Adaptive Randomization in a Limited-Resource Environment. Hyung Woo Kim, Ph.D. Takeda Global R & D Center, Inc. Donald A. Berry, Ph.D. M.D. Anderson Cancer Center. Overview. Phase 2a designs in oncology

646 views • 49 slides

Topics in Clinical Trials (4) -2012

Topics in Clinical Trials (4) -2012. J. Jack Lee, Ph.D. Department of Biostatistics University of Texas M. D. Anderson Cancer Center. Objectives of Phase I Trials. Determine Maximum tolerated dose (MTD) Optimal biological dose (OBD) Recommend phase II dose (RPTD)

649 views • 46 slides

512 views • 30 slides

Why and how people use R

365 views • 24 slides

Cancer Clinical Trials Aimed at Decreasing Toxicity

Cancer Clinical Trials Aimed at Decreasing Toxicity. The key goals of this workshop are to:. 1) recommend best (preclinical) practices for efficiently evaluating and developing agents in the CMCR pipeline for possible applications in cancer patients

234 views • 22 slides

Performance and Optimization of LC-MS/MS Platforms for Unbiased Discovery of Biomarker Candidates

http://proteomics.cancer.gov. Performance and Optimization of LC-MS/MS Platforms for Unbiased Discovery of Biomarker Candidates. Daniel C. Liebler Vanderbilt University School of Medicine Vanderbilt, Tennessee.

376 views • 19 slides

Starting a Medical Device Company: A Case Study

331 views • 17 slides

Hector Bill Presenter

Hector Bill Presenter. Digestive Health and Wellness. Research.

273 views • 12 slides

Cladribine + Rituximab in HCL : UPDATE

341 views • 11 slides

Neuroendocrine Tumors

Neuroendocrine Tumors. James C. Yao, MD Associate Professor Deputy Chairman, Gastrointestinal Medical Oncology University of Texas M. D. Anderson Cancer Center. Neuroendocrine Tumors. Spectrum of neoplasms. WHO classification Well differentiated neuroendocrine tumor

1.92k views • 10 slides

Overview of Clayton Biotechnologies, Inc.

Overview of Clayton Biotechnologies, Inc. To conduct medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind, and.

220 views • 9 slides

Cytotechnologist

Cytotechnologist. DEBBIE A. MCKNIGHT. Cytotechnologist -are special trained Medical Technologists. Examine the cells microscopically for color, size, shape, structure and pattern for disease and treatment of illness. Process tissues and body fluids for testing

368 views • 9 slides

Overview of Clayton Biotechnologies, Inc.

Overview of Clayton Biotechnologies, Inc. To conduct medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind.

271 views • 8 slides

Global Pleural effusion Market Research Report, Analysis, Opportunities, Forecast, Size, Segmentation, Competitive Analy

A pleural effusion referred to the “water on the lungs”, an unusual amount of fluid around the lung. This surplus fluid can harm breathing by limiting the expansion of the lungs. Thin membranes, called pleura, cover the outside of the lungs and the inside of the chest cavity. Depending on the nature of the fluid caused the entry of various kinds of pleural effusion which includes hydrothorax (serous fluid), hemothorax (blood), chylothorax (chyle), urinothorax (urine), or pyothorax (pus). To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/pleural-effusion-clinical-trials/150632-91.html Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications sales@kenresearch.com 91-9015378249

106 views • 6 slides

Ray Hachem, MD The University of Texas M. D. Anderson Cancer Center 1515 Holcombe Blvd.

Ray Hachem, MD The University of Texas M. D. Anderson Cancer Center 1515 Holcombe Blvd. Department of Infectious Diseases, Infection Control and Employee Health Unit 402 Houston, TX 77030 rhachem@mdanderson.org.

171 views • 1 slides

Abstract

Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation Therapy (3D-CRT); A Comparative Study Erik Frija M.A., Charles E. Poole B.S., R.T. (T), Chris Spicer R.T. (R)(T), C.M.D.

222 views • 1 slides

Sponsored by Division of Pathology & Laboratory Medicine and Department of Molecular pathology

221 views • 1 slides